Policy Briefs
- 2012
- 18 Apr 2012 HAI Europe & TACD Policy Paper – Time for the EU to lead on innovation EU – Policy opportunities in biomedical innovation and the promotion of public knowledge goods.
- 18 Apr 2012 HAI Europe & TACD Executive Summary – Time for the EU to lead on innovation
- 27 Feb 2012 HAI Europe Policy Brief – ACTA and Access to Medicines: A flawed process, flawed rationale and flawed agreement
- 2011
- 29 Nov 2011 Executive Summary EU Policy Opportunities in Biomedical Innovation and the Public Good
- 29 Apr 2011 Policy Brief EU-Mercosur Protecting Acccess to Medicines
- 2010
- 25 Oct 2010 Joint Policy Brief ACTA, Democracy & Access to Medicines
- 13 Sep 2010 Joint Policy Brief Ammendments to Information to Patients (EN)
- 13 Sep 2010 Joint Policy Brief Ammendments to Information to Patients (FR)
- 19 Feb 2010 Policy Brief A2M in Jeopardy- Central America in Negotiations with the EU
- 2009
- 1 May 2009 Policy Brief Protecting Access to Medicines in the Andean Region
- 23 Mar 2009 Policy Brief Deconstructing EC Meaning of Information to Patients + Annex
- 6 Mar 2009 Joint Policy Brief Legal Proposals on Information to Patients
- 9 Feb 2009 Policy Brief Deconstructing EC Meaning of Information to Patients (PT)
- 2008
- 2 Dec 2008 Policy Brief EU-CAN Access to Medicines in Jeopardy
- 3 Sep 2008 Policy Brief EU-CAN The EU Andean AA Negotiations
- 2006
- 1 Oct 2006 Joint declaration Relevant Health Information
- 2001
- Dec 2001 Policy Brief European Commission’s Proposals for DTCA Legislative Change (FR)
- Dec 2001 Policy Brief European Commission’s Proposals for DTCA Legislative Change (EN)
Factsheets
- The Investment Chapter of the EU-India FTA: Implications for Health
- Financing public interest organisations in the EU Health Policy Forum
- Nimesulide in Europe – Chronology
- The next chapter in promotion to healthcare professionals: Nurse prescribers
- Antibiotic Resistance
- What is HAI Europe?
- HAI Europe Work Plan Brochure
- Patient & Consumer Voice and Pharmaceutical Industry Sponsorship
- Threatening Access to Medicines: the Negotiations Between the European Union and the Andean Community
- Intellectual Property and Access to Medicines: The European Union- Andean Community Trade Agreements
- Patient & Consumer Organisations at the European Medicines Agency: Financial disclosure & transparency
- Direct-to-Consumer Advertising (DTCA) of Prescription Medicines
- Direct-to-Consumer Advertising (DTCA) of Prescription Medicines Chronology
- Access for All – Making Medicines Affordable in Portugal
- Medicines Reimbursement in Poland
